Project
ALTITUDE
Completed ยท 2007 until 2011
Rickli Hans
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2007
End Date
2011
Financing
Industry
Study Design
Randomized, double-blind, placebo-controlled, parallel-group Study.
Keywords
-
Brief description/objective
A randomized, double-blind, placebo-controlled, parallel-group study to determine whether, in patients with type 2 diabetes at high risk for cardiovascular and renal events, aliskiren, on top of conventional treatment, reduces cardiovascular and renal morbidity and mortality.
ALTITUDE : ALiskiren Trial In Type 2 diabetes Using cardio-renal Disease Endpoints (CSPP100E2337)